Medisyn Technologies inks licensing deal with Kraft

In its hunt to create products that can offer health and wellness benefits, Kraft Foods has inked a licensing deal with Medisyn Technologies, a research company based in Minnetonka, Minnesota.

Financial terms of the deal were not disclosed.

The agreement allows the food giant to license a portfolio of ingredients that Medisyn and Kraft have uncovered during a two-year collaboration. The goal of the partnership was to discover effective bioactive ingredients suitable for use in foods.

“This is a significant milestone for Medisyn and it demonstrates how technology can be a powerful tool in the discovery of new compounds that can provide important health and wellness benefits,” said David Land, president and CEO of Medisyn in a statement.

Medisyn uses molecular topology to expedite the discovery of bioactive compound and make the process more predictable and less expensive. That’s because molecular topology uses elaborate computer models to identify compounds that have the desired chemical features thatcompanies, for instance, pharmaceutical companies, are looking for when they are developing a drug or other bioactive compound.

According to a regulatory filing with the U.S. Securities & Exchange Commission, the company raised $1.5 million by issuing debt in late 2008.